These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3102630)

  • 1. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
    Livermore DM; Yang YJ
    J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.
    Jacobs JY; Livermore DM; Davy KW
    J Antimicrob Chemother; 1984 Sep; 14(3):221-9. PubMed ID: 6436226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
    Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
    J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
    Livermore DM
    Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
    Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ
    J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase.
    Livermore DM; Williams JD; Davy KW
    Chemioterapia; 1985 Feb; 4(1):28-35. PubMed ID: 3921264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Philippon A
    Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.
    Babini GS; Yuan M; Livermore DM
    Antimicrob Agents Chemother; 1998 May; 42(5):1168-75. PubMed ID: 9593145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa.
    Ben-Mahrez K; Rejiba S; Belhadj C; Belhadj O
    Res Microbiol; 1999; 150(6):403-6. PubMed ID: 10466408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.
    Tausk F; Evans ME; Patterson LS; Federspiel CF; Stratton CW
    Antimicrob Agents Chemother; 1985 Jul; 28(1):41-5. PubMed ID: 3929679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
    Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
    Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of FCE 22101 with class I beta-lactamases.
    Yang Y; Livermore DM
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():85-94. PubMed ID: 2786519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.
    Hoffman TA; Cleary TJ; Bercuson DH
    J Antibiot (Tokyo); 1981 Oct; 34(10):1334-40. PubMed ID: 6796556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae.
    Yang YJ; Livermore DM; Williams RJ
    J Med Microbiol; 1988 Mar; 25(3):227-33. PubMed ID: 3258037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
    Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
    J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii.
    Stapleton P; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Sep; 36(3):483-96. PubMed ID: 8830012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.